Lynn E. Bayless
General Counsel bei MUSTANG BIO, INC.
Profil
Lynn E.
Bayless is a professional with experience in regulatory affairs.
Currently, Bayless is the Head of Regulatory Affairs at Mustang Bio, Inc. Prior to this, Bayless held the position of Senior Director of Regulatory Affairs at Nightstar Therapeutics Ltd.
from 2018 to 2020.
From 2015 to 2018, Bayless worked as the Director of Regulatory Affairs at Voyager Therapeutics, Inc. Bayless has an undergraduate degree from Quinnipiac University and a graduate degree from Massachusetts College of Pharmacy & Health Science.
Aktive Positionen von Lynn E. Bayless
| Unternehmen | Position | Beginn |
|---|---|---|
| MUSTANG BIO, INC. | General Counsel | 01.01.2020 |
Ehemalige bekannte Positionen von Lynn E. Bayless
| Unternehmen | Position | Ende |
|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | General Counsel | 01.02.2020 |
| VOYAGER THERAPEUTICS, INC. | General Counsel | 01.10.2018 |
Ausbildung von Lynn E. Bayless
| Massachusetts College of Pharmacy & Health Science | Graduate Degree |
| Quinnipiac University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| MUSTANG BIO, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
